Impact of early versus later fluoroquinolone treatment on the clinical; microbiological and resistance outcomes in a mouse-lung model of Pasteurella multocida infection

Veterinary Microbiology

Volumn 148, Issue 2-4, 2011, Pages 292-297

  Ferran, Aude A ^a   Toutain, Pierre Louis ^a   Bousquet Mélou, Alain ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Antimicrobial resistance; Early treatment; Fluoroquinolone; Marbofloxacin; Metaphylaxis; Pasteurella multocida

Indexed keywords

MARBOFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; DRUG BLOOD LEVEL; FEMALE; LUNG INFECTION; MOUSE; NONHUMAN; PASTEURELLA MULTOCIDA INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; FLUOROQUINOLONES; LUNG; MICE; MICROBIAL SENSITIVITY TESTS; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; RESPIRATORY TRACT INFECTIONS; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); MUS; PASTEURELLA MULTOCIDA;

EID: 79951581241     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.09.005     Document Type: Article

References (18)

1. Aarestrup F.M., Wegener H.C. The effects of antibiotic usage in food animals on the development of antimicrobial resistance of importance for humans in Campylobacter and Escherichia coli. Microbes Infect. 1999, 1:639-644.
2. Blondeau J.M., Zhao X., Hansen G., Drlica K. Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 2001, 45:433-438.
3. CLSI Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard, Document M7-A7 2006, NCCLS, Wayne, PA. seventh ed.
4. Ferran A., Dupouy V., Toutain P.L., Bousquet-Melou A. Influence of inoculum size on the selection of resistant mutants of Escherichia coli in relation to mutant prevention concentrations of marbofloxacin. Antimicrob. Agents Chemother. 2007, 51:4163-4166.
5. Ferran A.A., Kesteman A.S., Toutain P.L., Bousquet-Melou A. Pharmacokinetic/pharmacodynamic analysis of the influence of inoculum size on the selection of resistance in Escherichia coli by a quinolone in a mouse thigh bacterial infection model. Antimicrob. Agents Chemother. 2009, 53:3384-3390.
6. Gibaldi M., Perrier D. Pharmacokinetics 1982, vol. 15. Marcel Dekker Inc.
7. Hammerum A.M., Heuer O.E. Human health hazards from antimicrobial-resistant Escherichia coli of animal origin. Clin. Infect. Dis. 2009, 48:916-921.
8. Ismail M., El-Kattan Y.A. Comparative pharmacokinetics of marbofloxacin in healthy and Mannheimia haemolytica infected calves. Res. Vet. Sci. 2007, 82:398-404.
9. Jumbe N., Louie A., Leary R., Liu W., Deziel M.R., Tam V.H., Bachhawat R., Freeman C., Kahn J.B., Bush K., Dudley M.N., Miller M.H., Drusano G.L. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. J. Clin. Invest. 2003, 112:275-285.
10. Kesteman A.S., Ferran A.A., Perrin-Guyomard A., Laurentie M., Sanders P., Toutain P.L., Bousquet-Melou A. Influence of inoculum size and marbofloxacin plasma exposure on the amplification of resistant subpopulations of Klebsiella pneumoniae in a rat lung infection model. Antimicrob. Agents Chemother. 2009, 53:4740-4748.
11. Kesteman A.S., Perrin-Guyomard A., Laurentie M., Sanders P., Toutain P.L., Bousquet-Melou A. Emergence of resistant Klebsiella pneumoniae in the intestinal tract during successful treatment of Klebsiella pneumoniae lung infection in rats. Antimicrob. Agents Chemother. 2010, 54:2960-2964.
12. Lo N., Cullen M. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider. Hematol. Oncol. 2006, 24:120-125.
13. Mizunaga S., Kamiyama T., Fukuda Y., Takahata M., Mitsuyama J. Influence of inoculum size of Staphylococcus aureus and Pseudomonas aeruginosa on in vitro activities and in vivo efficacy of fluoroquinolones and carbapenems. J. Antimicrob. Chemother. 2005, 56:91-96.
14. Morrissey I., George J.T. The effect of the inoculum size on bactericidal activity. J. Antimicrob. Chemother. 1999, 43:423-425.
15. Peyrou M., Doucet M.Y., Vrins A., Concordet D., Schneider M., Bousquet-Melou A. Population pharmacokinetics of marbofloxacin in horses: preliminary analysis. J. Vet. Pharmacol. Ther. 2004, 27:283-288.
16. Phillips I., Casewell M., Cox T., De Groot B., Friis C., Jones R., Nightingale C., Preston R., Waddell J. Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data. J. Antimicrob. Chemother. 2004, 53:28-52.
17. Udekwu K.I., Parrish N., Ankomah P., Baquero F., Levin B.R. Functional relationship between bacterial cell density and the efficacy of antibiotics. J. Antimicrob. Chemother. 2009, 63:745-757.
18. Young C. Antimicrobial metaphylaxis for undifferentiated bovine respiratory-disease. Comp. Cont. Ed. Pract. Vet. 1995, 17:133.